Grzanka A et al.,Pneumonol. Alergol. Pol. 2009; 77: 387–393. Rogliani P et al., Curr Res Pharmacol Drug Discov. 2020 Dec 13;2:100009. Calzetta L et al., Int J Chron Obstruct Pulmon Dis. 2021 Feb 12;16:257-279.
Slajd 4
Kim, Lisa H Y et al. “Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.” JAMA vol. 325,24 (2021): 2466-2479. doi:10.1001/jama.2021.7872
Kucharczyk A, Bednarek-Papierska L, Barczyk A, et al. Principles of management of severe asthma patients treated with systemic glucocorticosteroids – Experts’ recommendations on dose reduction and discontinuation of these drugs. Alergologia Polska - Polish Journal of Allergology. 2022;9(2):70-77. doi:10.5114/pja.2022.116292.
Slajd 7 i 8
Kucharczyk A, Bednarek-Papierska L, Barczyk A, et al. Principles of management of severe asthma patients treated with systemic glucocorticosteroids – Experts’ recommendations on dose reduction and discontinuation of these drugs. Alergologia Polska - Polish Journal of Allergology. 2022;9(2):70-77. doi:10.5114/pja.2022.116292.
Slajd 9
Leki biologiczne w Polsce – programy lekowe B.44
Slajd 10
Hekking et al, JACI 2015
Slajd 11
Analiza HTA PTA 2023
Slajd 12
Globalna Inicjatywa na rzecz Zwalczania Astmy (GINA). Globalna Strategia Leczenia i Profilaktyki Astmy (aktualizacja z 2023 r.). Dostępny na stronie: https://ginasthma.org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf [dostęp: listopad.2023 r.]; 2. Clark VL i wsp. ERJ Open Res 2021;7:00497–2020.